ARTICLE | Financial News
ImmunoMet completes venture financing
March 14, 2016 7:00 AM UTC
ImmunoMet Therapeutics, Houston, Texas Business: Cancer Date completed: 2016-03-08 Type: Venture financing Raised: $5.2 million Investors: Mirae Asset Venture Investment; Aju Tech; GNTech; MetaVest ...